# China NMPA Drug Inspection - Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd. - Schisandra chinensis

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/lushi-county-zhongkang-traditional-chinese-medicine-pieces-co-ltd/ff3e2ca5-f634-443e-859e-73a603d56890/
Source feed: China

> China NMPA drug inspection for Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd. published December 06, 2017. Drug: Schisandra chinensis. The Henan Provincial Food and Drug Administration, operating within China's regulatory framework, issued an announcement

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Announcement from Henan Provincial Food and Drug Administration Regarding 5 Batches of Substandard Drugs Found in Spot Checks
- Company Name: Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd.
- Publication Date: 2017-12-06
- Drug Name: Schisandra chinensis
- Inspection Finding: The non-compliant item was impurities.
- Action Taken: The Henan Provincial Food and Drug Administration has instructed relevant food and drug regulatory departments to take necessary risk control measures such as sealing, seizing, and suspending sales of substandard drugs, and to investigate and punish the units that sourced the samples in accordance with the law.
- Summary: The Henan Provincial Food and Drug Administration, operating within China's regulatory framework, issued an announcement on December 6, 2017, detailing findings from drug inspections. This announcement identified five batches of substandard drugs from three companies: Henan Baiyuankang Pharmaceutical Co., Ltd., Yuzhou Jindi Traditional Chinese Medicine Pieces Co., Ltd., and Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd.Henan Baiyuankang Pharmaceutical Co., Ltd. was cited for two batches: Psoralea corylifolia (batch 160401) was deemed generally substandard, and Fried Ziziphus jujuba var. spinosa (batch 160401) failed due to excessive moisture content. Yuzhou Jindi Traditional Chinese Medicine Pieces Co., Ltd.'s Atractylodes lancea (batch 150201) was found substandard regarding its active content. Lastly, Lushi County Zhongkang Traditional Chinese Medicine Pieces Co., Ltd. had two batches fail: Lycium barbarum (batch 160401) for moisture and Schisandra chinensis (batch 170501) for impurities.In response to these violations, the Henan Provincial Food and Drug Administration mandated immediate risk control measures. These actions included sealing, seizing, and suspending the sale of the affected drug batches. Additionally, relevant regulatory departments were instructed to conduct thorough investigations and impose legal penalties on the manufacturing and sourcing units responsible for the substandard products, underscoring a commitment to pharmaceutical quality and safety.

Company: https://www.globalkeysolutions.net/companies/lushi-county-zhongkang-traditional-chinese-medicine-pieces-co-ltd/90840d5c-5e71-415b-a1b2-008672c7da2c/